Sort
48,018 grants matching “immunotherapy”
iSTAR Tregs
$969,000Qizhi Tang · University Of California, San Francisco · U01 · FY2023 · DK
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center
$968,937William C Hahn · Dana-Farber Cancer Inst · U01 · FY2019 · CA
IDENTIFICATION AND ASSESSMENT OF TARGETS FOR IMMUNOTHERAPY IN NF2-ASSOCIATED SCHWANNOMATOSIS
$968,875H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. · · FY2025 · Defense Health Agency
iSTAR Tregs
$968,858Qizhi Tang · University Of California, San Francisco · U01 · FY2024 · DK
iSTAR Tregs
$968,716Qizhi Tang · University Of California, San Francisco · U01 · FY2025 · DK
Thoracic and Gastrointestinal Malignancies Branch Clinical Core
$968,567Raffit Hassan · Division Of Basic Sciences - Nci · ZID · FY2025 · CA
Understanding and Addressing Cancer Health Disparities in Louisiana
$968,492Augusto C Ochoa · Lsu Health Sciences Center · P20 · FY2020 · CA
Elucidating and Targeting tumor dependencies and drug resistance determinants at the single cell level
$967,866Andrea Califano · Columbia University Health Sciences · U01 · FY2025 · CA
Broadly neutralizing SARS-CoV-2 peptidic knobs
$967,225Vaughn Vasil Smider · Applied Biomedical Science Institute · R01 · FY2023 · AI
Combination Immunotherapy of a Novel Superagonist IL-15 Complex and Anti-CD20 Antibody for Indolent Non-Hodgkin Lymphoma
$966,343Hing C. Wong · Altor Bioscience. Llc · R44 · FY2016 · CA
Molecular mechanisms of antibody-mediated immunotherapies
$966,151Jeffrey Victor Ravetch · Rockefeller University · R35 · FY2024 · CA
Biology and genetics of metastatic disease
$966,151Sohail F. Tavazoie · Rockefeller University · R35 · FY2024 · CA
Delaware Christiana Care CCOP
$966,057Christiana Care Health Services, Inc. · U10 · FY2005 · CA
Reprogramming of T cells for the Treatment of Melanoma
$965,794Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2013 · CA
DEVELOPMENTAL FUNDS (Core 002)
$965,723Henry Shelton Earp · Univ Of North Carolina Chapel Hill · P30 · FY2020 · CA
Targeting Epigenetic Circuits in B-Cell Lymphomas
$965,684Ari M. Melnick · Weill Medical Coll Of Cornell Univ · R35 · FY2024 · CA
Development
$965,464Ana M Navarro · University Of California, San Diego · U54 · FY2012 · CA
Cellular Interactions with Thrombospondin
$965,406David D Roberts · Division Of Clinical Sciences - Nci · ZIA · FY2024 · CA
Fruit exosome-like particles for therapeutic delivery of extracellular miRNAs
$965,386Huang-Ge Zhang · University Of Louisville · UH3 · FY2017 · TR
A Phase II Trial of Rituximab In Myasthenia Gravis
$964,955Richard Nowak · Yale University · U01 · FY2016 · NS
Improved Treatment of Colorectal Cancer with CF10
$964,465William H Gmeiner · Deep Creek Pharma, Llc · R42 · FY2023 · CA
Metabolic reprogramming of the tumor microenvironment and therapy resistance
$964,319Ernst Lengyel · University Of Chicago · R35 · FY2023 · CA
Metabolic reprogramming of the tumor microenvironment and therapy resistance
$964,319Ernst Lengyel · University Of Chicago · R35 · FY2022 · CA
Spatial functional genomics to identify regulators of the tumor microenvironment and cancer immunity
$964,277Brian D Brown · Icahn School Of Medicine At Mount Sinai · U01 · FY2024 · CA
Molecular, Cellular, and Tissue Characterization Unit
$964,136William E Gillanders · Washington University · U2C · FY2019 · CA